KRAS and pancreatic adenocarcinoma: The prevalent mutations associated with G12V KRAS in PAAD are R175H, R273H, and R282W co-mutations of TP53 (Figure 6A), while R175H and R273H mutations are prevalent with G12V KRAS co-mutation in the case of CRAD (Figure 6B).